Lessons to be learned from the NOD2 gene in Crohn's disease

European Journal of Gastroenterology and Hepatology

Volumn 15, Issue 6, 2003, Pages 593-597

  Hugot, Jean Pierre ^a,b,c   Zouali, Habib ^a   Lesage, Suzane ^a  

^a FONDATION JEAN DAUSSET CEPH   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c Fondation Jean Dausset   (France)

Author keywords

CARD15; Crohn's disease; Genetics; Inflammatory bowel disease; Innate immunity; NOD2

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UNCLASSIFIED DRUG;

BACTERIAL FLORA; CHROMOSOME MUTATION; CLINICAL PRACTICE; CROHN DISEASE; DIGESTIVE SYSTEM; GENE ACTIVATION; GENE MUTATION; GENETIC DISORDER; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; PATHOGENESIS; POPULATION RISK; PRIORITY JOURNAL; REVIEW;

CARRIER PROTEINS; CHROMOSOME MAPPING; CROHN DISEASE; DNA MUTATIONAL ANALYSIS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN;

EID: 0038460133     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200306000-00003     Document Type: Review

References (30)

1. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411:599-603. The authors demonstrate by a positional cloning approach that several CARD15/NOD2 variants are associated with susceptibility to CD.
2. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411:537-539. The authors demonstrate by a candidate gene approach the association of a frameshift variant of CARD15/NOD2 with CD. They show that it is associated with hyporesponsiveness in NFκB activation by lipopolysaccharide.
3. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001; 357:1925-1928.
4. Ahmad T, Armuzzi A, Bunce M, Mulcahy-Hawes K, Marshall SE, Orchard TR, et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 2002; 122:854-866.
5. Cuthbert AP, Fisher SA, Mirza MM, King K, Hampe J, Croucher PJP, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002; 122:867-874.
6. Vermeire S, Wild G, Kocher K, Cousineau J, Dufresne L, Bitten A, et al. CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet 2002; 71:74-83.
7. Murillo L, Crusius JB, van Bodegraven AA, Alizadeh BZ, Pena AS. CARD15 gene and the classification of Crohn's disease. Immunogenetics 2002; 54:59-61.
8. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996; 379:821-823.
9. Satsangi J, Parkes M, Louis E, Hashimoto L, Kato N, Welsh K, et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nature Genetics 1996; 14:199-202.
10. Hampe J, Schreiber S, Shaw SH, Lau KF, Bridger S, Macpherson AJ, et al. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet 1999; 64:808-816.
11. Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, McLeod RS, Griffiths AM, et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000; 66:1863-1870.
12. Cho JH, Nicolae DL, Gold LH, Fields CT, LaBuda MC, Rohal PM, et al. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci USA 1998; 95:7502-7507.
13. Duerr RH, Barmada MM, Zhang L, Pfutzer R, Weeks DE. High-density genome scan in Crohn's disease shows confirmed linkage to chromosome 14q11-12. Am J Hum Genet 2000; 66:1857-1862.
14. Hampe J, Shaw SH, Saiz R, Leysens N, Lantermann A, Mascheretti S, et al. Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet 1999; 65:1647-1655.
15. Rioux JD, Daly MJ, Silverberg MS, Lindblad K, Steinhart H, Cohen Z, et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nature Genetics 2001; 29:223-228. Identification of a common haplotype in the 5q31 cytokine gene cluster which is highly associated with CD.
16. Ogura Y, Inohara N, Benito A, Chen FF, Nuñez G. Nod2, a Nod1/Apaf1 family member that is restricted to monocytes and activates NF-kB. J Biol Chem 2001; 276:4812-4818. Initial characterization of Nod2 expression in peripheral blood monocytes, as well as its role in NFκB activation.
17. Lesage S, Zouali H, Cézard JP and the EPWG-IBD, Colombel JF and EPIMAD, Belaiche J and the GETAID, Almer S, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002; 70:845-857. This work provides the mutational spectrum of CARD15.
18. Yamazaki K, Takazoe M, Tanaka T, Kazumori T, Nakamura Y. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet 2002; 47:469-472.
19. Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Takahashi S, Ogura Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002; 123:86-91.
20. Abreu MT, Taylor KD, Lin YC, Hang T, Gaiennie J, Landers CJ, et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 2002; 123:679-688.
21. Hampe J, Grebe J, Nikolaus S, Solberg C, Croucher PJ, Mascheretti S, et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 2002; 359:1661-1665.
22. Radlmayr M, Torok HP, Martin K, Folwaczny C. The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease. Gastroenterology 2002; 122:2091-2092.
23. Vermeire S, Louis E, Rutgeerts P, De Vos M, Van Gossum A, Belaiche J, et al. NOD2/CARD15 does not influence response to infliximab in Crohn's disease. Gastroenterology 2002; 123:106-111.
24. Mascheretti S, Hampe J, Croucher PJ, Nikolaus S, Andus T, Schubert S, et al. Response to infliximab treatment in Crohn's disease is not associated with mutations in the CARD15 (NOD2) gene: an analysis in 534 patients from two multicenter, prospective GCP-level trials. Pharmacogenetics 2002; 12:509-515.
25. Gutierrez O, Pipaon C, Inohara N, Fontalba A, Ogura Y, Prosper F, et al. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kB activation. J Biol Chem 2002; (published on line).
26. Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, Hafner R, et al. CARD15 mutations in Blau syndrome. Nature Genetics 2001; 29:19-20. This work demonstrates the link between CARD15 and another granulomatous condition - Blau syndrome.
27. Inohara N, Ogura Y, Chen FF, Muto A, Nuñez G. Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J Biol Chem 2001; 276:2551-2554.
28. Beutler B. Autoimmunity and apoptosis: the Crohn's connection. Immunity 2001; 15:5-14.
29. Kobayashi K, Inohara N, Hernandez LD, Galan JE, Nunez G, Janeway CA, et al. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002; 416:194-199.
30. Elson CO. Genes, microbes, and T cells - new therapeutic targets in Crohn's disease. N Engl J Med 2002; 346:614-616.